Early-onset colorectal cancer: symptoms, risk factors, and when to seek care.
More younger adults are hearing about colorectal cancer, and it's understandable to have questions. Most symptoms in younger adults are not caused by cancer — but persistent symptoms shouldn't be ignored. This guide helps you tell the difference between routine screening, higher-risk screening, and symptoms worth discussing with a clinician.
- Most younger adults with symptoms do not have colorectal cancer — but persistent symptoms should not be ignored.
- Talk to a clinician about rectal bleeding, blood in or black stool, persistent bowel-habit changes, unexplained weight loss, iron-deficiency anemia, or abdominal pain that doesn't go away.
- Routine average-risk screening usually begins at age 45 — but symptoms or family history can change your next step.
Where do you fit right now?
Three common situations. Start with the one that sounds most like you.
I have symptoms
Bleeding, persistent bowel-habit changes, unexplained anemia, weight loss, or abdominal pain should be discussed with a clinician. Symptoms are different from routine screening.
See the symptoms pathwayI have family history
A parent, sibling, child, or multiple relatives with colorectal cancer or advanced polyps may change when screening should start and how often it should be repeated.
Review family-history guidanceI'm 45+ with no symptoms
Most average-risk adults should begin colorectal cancer screening at age 45. Several options exist, including colonoscopy and stool-based tests.
Check if I'm dueWhy younger adults are paying attention.
Colorectal cancer has traditionally been thought of as a disease affecting older adults, but cases in younger adults have received increasing attention. This doesn't mean every symptom is cancer — it means persistent symptoms deserve thoughtful evaluation. It's also why screening guidance for average-risk adults now begins at 45 rather than 50.
Awareness shouldn't create panic. The goal is to know which symptoms matter, understand your family history, and take appropriate action instead of guessing.
Awareness is useful when it leads to the right next step.
Symptoms that shouldn't be ignored.
Discuss these with a clinician
- Rectal bleeding or blood in the stool
- Black or tarry stool
- New, persistent diarrhea, constipation, or change in bowel habits
- Feeling like the bowel doesn't empty completely
- Persistent abdominal pain or cramping
- Unexplained weight loss
- Iron-deficiency anemia
- An abnormal stool-based or blood-based screening test
Symptoms don't mean cancer — but they deserve evaluation.
Bleeding, bowel changes, abdominal pain, and anemia can come from many causes, including hemorrhoids, fissures, infections, inflammation, diet changes, medications, and other non-cancer conditions.
The important point is not to self-diagnose or ignore symptoms that persist. If symptoms are new, unexplained, recurrent, or worsening, talk with a healthcare professional about whether diagnostic evaluation is needed.
Being younger than 45 shouldn't be used as a reason to ignore persistent symptoms.
Family history and inherited risk.
A family history of colorectal cancer or advanced colon polyps can change when screening should begin, which test may be preferred, and how often it should be repeated. It's especially important to know whether a parent, sibling, or child was affected, and how old they were at diagnosis.
GI specialty guidance notes that some people with a first-degree relative affected by colorectal cancer or advanced polyps may need screening earlier than age 45 — often around age 40, or 10 years before the youngest affected relative, depending on the details. In some higher-risk situations, colonoscopy may be preferred over stool-based testing.
It helps to know
- Which relative was affected
- Whether they had cancer or advanced polyps
- Their age at diagnosis
- Whether multiple relatives were affected
- Whether you've had colon polyps yourself
- Whether there's a known hereditary cancer syndrome, such as Lynch syndrome or FAP
Screening vs. diagnostic evaluation.
Screening is for people who do not have symptoms. Diagnostic evaluation is for people who have symptoms, iron-deficiency anemia, or an abnormal stool-based or blood-based screening test.
This distinction is important. GI specialty guidance emphasizes that stool-based screening tests are part of a two-step process: if the result is abnormal, colonoscopy is generally needed to complete the evaluation. Colonoscopy is considered a one-step test because polyps can be found and removed during the same procedure.
Stool-based screening tests are not meant to explain symptoms. If you have rectal bleeding, persistent bowel changes, unexplained anemia, unexplained weight loss, or a positive stool test, talk to a clinician about the right diagnostic next step.
Screening is for people without symptoms. If you have persistent rectal bleeding, blood in stool, unexplained iron-deficiency anemia, unexplained weight loss, or a new bowel-habit change that doesn't go away, don't rely on a stool-based screening test to explain it — talk to a clinician about diagnostic evaluation.
Not sure which pathway fits you? Start with the ColonSmart screening checker.
Check My RiskQuestions to ask your clinician.
Bringing a few of these can make the conversation clearer and faster.
- Are my symptoms considered routine screening or diagnostic evaluation?
- Should I have a colonoscopy or another test?
- Does my family history change when I should start screening?
- If I do a stool test and it's positive, what happens next?
- How soon should I be evaluated?
- What records should I bring, such as prior colonoscopy or pathology reports?
- Am I considered average risk or higher risk?
What should I do next?
If you have symptoms
Talk with a clinician about diagnostic evaluation. Symptoms can have many causes, but persistent or unexplained symptoms should not be ignored.
Check the symptoms pathwayIf you have family history
Find out which relative was affected and their age at diagnosis. Family history can change when screening should start.
Review family-history guidanceIf you're 45+ with no symptoms
Routine colorectal cancer screening is recommended for most average-risk adults starting at age 45. Compare the options to see what fits.
Compare screening optionsIf you're preparing for colonoscopy
Good preparation helps your clinician see clearly and can reduce the chance the test needs to be repeated.
Read the prep guideCommon questions.
Can people under 45 get colorectal cancer?
Yes. Colorectal cancer can occur in younger adults, although it's still much less common than in older adults. Symptoms and family history matter. Younger adults with persistent rectal bleeding, blood in stool, unexplained iron-deficiency anemia, unexplained weight loss, or persistent bowel-habit changes should talk with a clinician.
Does rectal bleeding always mean colon cancer?
No. Rectal bleeding is often caused by non-cancer conditions such as hemorrhoids or fissures. However, persistent, unexplained, recurrent, or worsening bleeding should be evaluated rather than assumed to be benign.
Should I use a stool test if I have symptoms?
Stool-based screening tests are intended for people without symptoms. If you have symptoms, talk with a clinician about diagnostic evaluation instead of relying on a screening test to explain the symptoms.
When should average-risk adults start screening?
Most average-risk adults should begin colorectal cancer screening at age 45. People with symptoms, certain family histories, prior polyps, inflammatory bowel disease involving the colon, or hereditary cancer syndromes may need a different plan.
What if my parent had colon cancer?
A parent, sibling, or child with colorectal cancer or advanced polyps may change when screening should begin and how often it should be repeated. The age of the affected relative at diagnosis is important.
What happens after a positive stool test?
A positive stool-based or blood-based colorectal cancer screening test usually needs follow-up colonoscopy to complete the evaluation.
Why does ColonSmart ask about family history?
Family history can change colorectal cancer screening recommendations. A parent, sibling, child, or multiple relatives with colorectal cancer or advanced polyps may mean screening should begin earlier or occur more often. GI specialty guidance emphasizes risk stratification rather than giving everyone the same screening plan.
Why does ColonSmart ask about prior polyps?
Prior colon polyps can change future surveillance recommendations. The timing of the next colonoscopy depends on details such as the number, size, type, and pathology of prior polyps. If you've had polyps before, your prior colonoscopy and pathology reports are important.
Why might ColonSmart suggest a clinician review my answers?
Uncertainty about prior polyps, family history, inflammatory bowel disease, hereditary cancer syndromes, or prior screening can affect screening recommendations. When these details are unclear, it's safer to review them with a clinician rather than assume an average-risk pathway.
Guidance from GI specialists and public health organizations.
ColonSmart is designed around guidance from gastroenterology specialty societies and public health organizations — it's not a generic health website. GI specialty guidance from the American College of Gastroenterology, American Gastroenterological Association, and the U.S. Multi-Society Task Force emphasizes that screening should be based on age, symptoms, family history, prior polyps, hereditary risk, inflammatory bowel disease, and prior screening history.
Public health organizations such as the CDC, USPSTF, American Cancer Society, and National Cancer Institute provide additional patient-facing guidance on screening age, symptoms, screening options, and early-onset awareness.
Where this guidance comes from.
ColonSmart content is informed by guidance and educational material from gastroenterology specialty societies — the American College of Gastroenterology, American Gastroenterological Association, and U.S. Multi-Society Task Force on Colorectal Cancer — and from the CDC, USPSTF, American Cancer Society, and National Cancer Institute. Content is reviewed by a board-certified gastroenterologist before publication.